GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » Cyclically Adjusted Revenue per Share

Genetics Generation Advancement (ROCO:4160) Cyclically Adjusted Revenue per Share : NT$20.42 (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Genetics Generation Advancement's adjusted revenue per share for the three months ended in Mar. 2025 was NT$5.434. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$20.42 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Genetics Generation Advancement's average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Genetics Generation Advancement was 10.80% per year. The lowest was 10.20% per year. And the median was 10.50% per year.

As of today (2025-07-16), Genetics Generation Advancement's current stock price is NT$49.10. Genetics Generation Advancement's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was NT$20.42. Genetics Generation Advancement's Cyclically Adjusted PS Ratio of today is 2.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genetics Generation Advancement was 6.60. The lowest was 1.31. And the median was 1.70.


Genetics Generation Advancement Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Genetics Generation Advancement's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement Cyclically Adjusted Revenue per Share Chart

Genetics Generation Advancement Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.22 14.86 16.44 18.00 19.87

Genetics Generation Advancement Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.65 19.03 19.57 19.87 20.42

Competitive Comparison of Genetics Generation Advancement's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Genetics Generation Advancement's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetics Generation Advancement's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetics Generation Advancement's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Genetics Generation Advancement's Cyclically Adjusted PS Ratio falls into.


;
;

Genetics Generation Advancement Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genetics Generation Advancement's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=5.434/134.9266*134.9266
=5.434

Current CPI (Mar. 2025) = 134.9266.

Genetics Generation Advancement Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.251 100.684 4.357
201509 2.614 100.392 3.513
201512 2.650 99.792 3.583
201603 2.839 100.470 3.813
201606 3.096 101.688 4.108
201609 4.121 101.861 5.459
201612 3.103 101.863 4.110
201703 3.359 102.862 4.406
201706 3.266 103.349 4.264
201709 3.317 104.136 4.298
201712 3.616 104.011 4.691
201803 3.481 105.290 4.461
201806 3.562 106.317 4.521
201809 3.041 106.507 3.852
201812 3.990 105.998 5.079
201903 3.615 107.251 4.548
201906 4.298 108.070 5.366
201909 3.916 108.329 4.877
201912 4.197 108.420 5.223
202003 3.957 108.902 4.903
202006 4.030 108.767 4.999
202009 4.512 109.815 5.544
202012 4.301 109.897 5.281
202103 4.504 111.754 5.438
202106 5.266 114.631 6.198
202109 5.287 115.734 6.164
202112 4.547 117.630 5.216
202203 5.211 121.301 5.796
202206 5.655 125.017 6.103
202209 4.987 125.227 5.373
202212 4.625 125.222 4.983
202303 5.009 127.348 5.307
202306 5.503 128.729 5.768
202309 5.708 129.860 5.931
202312 5.870 129.419 6.120
202403 6.220 131.776 6.369
202406 6.303 132.554 6.416
202409 6.379 133.029 6.470
202412 5.769 133.157 5.846
202503 5.434 134.927 5.434

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Genetics Generation Advancement  (ROCO:4160) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Genetics Generation Advancement's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=49.10/20.42
=2.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genetics Generation Advancement was 6.60. The lowest was 1.31. And the median was 1.70.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Genetics Generation Advancement Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetics Generation Advancement Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines